Medicare Advantage insurers lose power to deny care after approving it
H.R. 10394 — Protecting Approved Care Act · Filed by Greg Landsman (D-OH) · 1 cosponsor · Introduced Sep 15, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill prohibits Medicare Advantage plans from denying coverage or reopening claims after they have already approved an item or service through prior authorization or concurrent approval. Once an MA plan approves care (either before or during treatment), it cannot later deny that same care as medically unnecessary, reopen the approval without good cause or fraud evidence, or reduce payment by recoding the claim—protecting patients from surprise denials after care is delivered.
Why we flagged it
The bill's operative mechanism is a straightforward restriction on MA insurers' post-approval claim-denial practices. It does not create new benefits or spending; it constrains insurer discretion after approval has been granted, protecting the enforceability of prior authorizations.
What the text implies
- MA plans may respond by tightening prior authorization criteria upfront, making initial approvals harder to obtain—shifting the denial burden earlier in the care pathway rather than eliminating it.
- The bill's effective date (January 1, 2028) gives MA plans 16+ months to reprogram claims systems and authorization workflows, potentially creating a window of uncertainty about implementation.
- Reopening restrictions tied to 'good cause' and 'reliable evidence of fraud' reference specific CFR sections (405.986, 422.616, 405.902); changes to those regulations could alter the bill's practical scope without amending this statute.
- The bill does not address the underlying prior authorization burden itself—only the post-approval reversal problem—so patients may still face delays and denials at the authorization stage.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Patients enrolled in Medicare Advantage plans gain protection against the practice of insurers approving care upfront and then denying or reducing payment after delivery. This reduces financial uncertainty and surprise bills for seniors, and ensures that prior approvals are binding commitments rather than provisional placeholders.
Who stands to gain
- Medicare Advantage enrollees (reduced risk of post-service claim denials)
- Healthcare providers (reduced claim reversals and payment uncertainty)
Named in the bill
Medicare Advantage organizations, Social Security Act § 1857(e), 42 CFR § 405.986, 42 CFR § 422.616, 42 CFR § 405.902
Where it stands
1 cosponsor: 1 Republicans.
- Sep 15, 2026 — Introduced · Congress.gov: “Introduced in House”
- Sep 15, 2026 — Referred to House Committee on Energy and Commerce and House Committee on Ways and Means · Congress.gov: “Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (2,966 characters) on Sep 23, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 14,707 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-09-23.
“Medicare Advantage insurers lose power to deny care after approving it” QuorumCivic. https://share.quorumcivic.app/bill/119/hr10394 Report an error